Renal failure
Conditions
Interventions
Treatment with EVAL membrane dialyzer.
Treatment with high performance membrane dialyzer.
Sponsors
E-HOPED-STUDY GROUP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All conditions are needed as inclusion criteria. 1)When patient are treated newly hemodialysis and 2-3 times consulted with hemodialysis, whose age isn't less than 70years old. 2)dialysis vintages is between 30 days and 179 days. 3)ambulatory patient. 4)no severe cardiovascular complication and no hospitalization. 5)few fementia. 6)provide written informed concent.
Exclusion criteria
Exclusion criteria: Someone condition is needed as exclusion criteria. 1)Primary disease is the following; rapidly progressive glomerulonephritis, pregnant toxicosis, polycystic kidney disease, amyloid kidney,microscopic polyangiitis, inborn error of metabolism based-renal failure, renal tumor, urinary tract tumor, obstructive uropathy, or myeloma. 2)Patient has been consulted with peritoneal dialysis. 3)Patient has been used vitamin E-bonded dialyzer. 4)Medical doctor judges patient who is unsuitble to registory on this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| cause of death, serum albumin, pre/post-dialysis serum creatinine, brain/cardiovascular event(included vascular access failure), rate of hospitalization, length of hospital stay, cause of hospitalization, newly complication, pre/post-dialysis body weight, blood pressure in pre/post-dialysis, dialysis condition, CTR, count of intradialytic first aid, residual urine volume, antihypertensive medication, pre/post-dialysis of BUN, body height, body mass index, geriatric nutritional risk index, CRP, beta-2 microglobulin, non-adjusted calcium, serum inorganic phosphate, intact-PTH | — |
Countries
Japan
Contacts
Public ContactMASAHIDE KOREMOTO
E-HOPED-STUDY GROUP Asahi Kasei Medical Co., LTD
Outcome results
None listed